NEW YORK (
CHANGE IN RATINGS
initiated at JP Morgan. Initiated with an Overweight rating and $40.50 price target. Introduces 2010 EPS estimates of $4.96.
(CAKE - Get Report)
upgraded at Baird from Neutral to Outperform. $32 price target. Company is seeing better sales and traffic trends.
Clear Channel Outdoor
upgraded at Piper Jaffray. Rating raised to Neutral from Underweight. Price target raised to $12 from $6. 2010 EPS estimates lowered to -$0.11 from -$0.04.
downgraded at UBS from Buy to Neutral. $11 price target. Estimates also lowered, given pricing pressures in the milk market.
upgraded at MKM from Sell to Neutral. Company is turning the business around and seeing better sales from its new titles.
upgraded at BofA/Merrill to Neutral from Underperform on cost savings, large buyback and better flows. Price target maintained at $31.
downgraded at Barclays to Equal Weight from Overweight on valuation. Maintain $14 price target.
upgraded at Deutsche from Hold to Buy. $14 price target. New plans should drive subscriber growth.
rated new Buy at Jefferies. $39 price target. Company should benefit from a resurgence in discretionary spending.
rated new Neutral at UBS. PRI was initiated with a Neutral rating. $27 price target. Company can deliver double-digit earnings growth by 2012, but faces compliance issues.
(SSNC - Get Report)
rated new Buy at Deutsche Bank. $19 price target. Industry trends are improving and organic growth could accelerate.
St Jude Medical
upgraded at Piper Jaffray to Overweight from Neutral. Maintains $44 price target and 2010 EPS estimates of $2.84.
initiated at Barclays with an Overweight rating and $23 price target. Sales are recovering broadly and the TLB story is just getting started.
estimates increased at Morgan Stanley through 2011. Protein market is improving and the company is seeing better operating efficiency. Equal-weight rating.
downgraded at Credit Suisse to Neutral from Outperform. Valuation call. Price target lowered to $21 from $23.
STOCK COMMENTS / EPS CHANGES
(AAPL - Get Report)
estimates, target raised at Kaufman. Shares of AAPL now seen reaching $320. Estimates also increased, given higher expected Mac and iPad sales. Buy rating.